The cytoprotective role of omentin against oxidative stress-induced PC12 apoptosis

References

• Jenner P, Olanow CW. Understanding cell death in Parkinson's disease. Ann Neurol. 1998;44(3 Suppl 1):S72–S84.
   PubMed Web of Science ®Google Scholar
• Zhang S, Tang M-B, Luo H-Y, et al. Necroptosis in neurodegenerative diseases: a potential therapeutic target. Cell Death Dis. 2017;8(6):e2905.
   PubMed Web of Science ®Google Scholar
• Schaeffer E, Pilotto A, Berg D. Pharmacological strategies for the management of levodopa-induced dyskinesia in patients with Parkinson's disease. CNS Drugs. 2014;28(12):1155–1184.
   PubMed Web of Science ®Google Scholar
• Niedzielska E, Smaga I, Gawlik M, et al. Oxidative stress in neurodegenerative diseases. Mol Neurobiol. 2016;53(6):4094–4125.
   PubMed Web of Science ®Google Scholar
• Fahn S, Cohen G. The oxidant stress hypothesis in Parkinson's disease: evidence supporting it. Ann Neurol. 1992;32(6):804–812.
   PubMed Web of Science ®Google Scholar
• Gilgun-Sherki Y, Melamed E, Offen D. Oxidative stress induced-neurodegenerative diseases: the need for antioxidants that penetrate the blood brain barrier. Neuropharmacology. 2001;40(8):959–975.
   PubMed Web of Science ®Google Scholar
• Klaunig JE, Wang Z, Pu X, et al. Oxidative stress and oxidative damage in chemical carcinogenesis. Toxicol Appl Pharmacol. 2011;254(2):86–99.
   PubMed Web of Science ®Google Scholar
• Fico A, Paglialunga F, Cigliano L, et al. Glucose-6-phosphate dehydrogenase plays a crucial role in protection from redox-stress-induced apoptosis. Cell Death Differ. 2004;11(8):823–831.
   PubMed Web of Science ®Google Scholar
• Radi E, Formichi P, Battisti C, et al. Apoptosis and oxidative stress in neurodegenerative diseases. JAD. 2014;42(s3):S125–S152.
   Web of Science ®Google Scholar
• Yang B, Oo TN, Rizzo V. Lipid rafts mediate H2O2 prosurvival effects in cultured endothelial cells. FASEB J. 2006;20(9):1501–1503.
   PubMed Web of Science ®Google Scholar
• Han Q, Wang H, Xiao C, et al. Oroxylin A inhibits H2O2-induced oxidative stress in PC12 cells. Nat Prod Res. 2017;31(11):1339–1342.
   PubMed Web of Science ®Google Scholar
• Chen L, Wu X, Shen T, et al. Protective effects of ethyl gallate on H2O2-induced mitochondrial dysfunction in PC12 cells. Metab Brain Dis. 2019;34(2):545–555.
   PubMed Web of Science ®Google Scholar
• Sies H. Hydrogen peroxide as a central redox signaling molecule in physiological oxidative stress: oxidative eustress. Redox Biol. 2017;11:613–619.
   PubMed Web of Science ®Google Scholar
• Christensen LL, Holm A, Rantala J, et al. Functional screening identifies miRNAs influencing apoptosis and proliferation in colorectal cancer. PLOS One. 2014;9(6):e96767.
   PubMed Web of Science ®Google Scholar
• Luu HN, Lin H-Y, Sørensen KD, et al. miRNAs associated with prostate cancer risk and progression. BMC Urol. 2017;17(1):18.
   PubMed Web of Science ®Google Scholar
• Chen J, Zhao D, Meng Q. Knockdown of HCP5 exerts tumor-suppressive functions by up-regulating tumor suppressor miR-128-3p in anaplastic thyroid cancer. Biomed Pharmacother. 2019;116:108966.
   PubMed Web of Science ®Google Scholar
• Zhao X, Jin Y, Li L, et al. MicroRNA-128-3p aggravates doxorubicin-induced liver injury by promoting oxidative stress via targeting Sirtuin-1. Pharmacol Res. 2019;146:104276.
   PubMed Web of Science ®Google Scholar
• Soreq L, Israel Z, Bergman H, et al. Advanced microarray analysis highlights modified neuro-immune signaling in nucleated blood cells from Parkinson's disease patients. J Neuroimmunol. 2008;201–202:227–236.
   PubMed Web of Science ®Google Scholar
• Soreq L, Guffanti A, Salomonis N, et al. Long non-coding RNA and alternative splicing modulations in Parkinson's leukocytes identified by RNA sequencing. PLOS Comput Biol. 2014;10(3):e1003517.
   PubMed Web of Science ®Google Scholar
• Liu EY, Cali CP, Lee EB. RNA metabolism in neurodegenerative disease. Dis Model Mech. 2017;10(5):509–517.
   PubMed Web of Science ®Google Scholar
• Hanan M, Simchovitz A, Yayon N, et al. A Parkinson's disease CircRNAs Resource reveals a link between circSLC8A1 and oxidative stress. EMBO Mol Med. 2020;12(9):e11942.
   PubMed Web of Science ®Google Scholar
• Batista CMdS, Yang R-Z, Lee M-J, et al. Omentin plasma levels and gene expression are decreased in obesity. Diabetes. 2007;56(6):1655–1661.
   PubMed Web of Science ®Google Scholar
• Yan P, Li L, Yang M, et al. Effects of the long-acting human glucagon-like peptide-1 analog liraglutide on plasma omentin-1 levels in patients with type 2 diabetes mellitus. Diabetes Res Clin Pract. 2011;92(3):368–374.
   PubMed Web of Science ®Google Scholar
• Yamawaki H, Tsubaki N, Mukohda M, et al. Omentin, a novel adipokine, induces vasodilation in rat isolated blood vessels. Biochem Biophys Res Commun. 2010;393(4):668–672.
   PubMed Web of Science ®Google Scholar
• Yamawaki H, Kuramoto J, Kameshima S, et al. Omentin, a novel adipocytokine inhibits TNF-induced vascular inflammation in human endothelial cells. Biochem Biophys Res Commun. 2011;408(2):339–343.
   PubMed Web of Science ®Google Scholar
• Kataoka Y, Shibata R, Ohashi K, et al. Omentin prevents myocardial ischemic injury through AMP-activated protein kinase- and Akt-dependent mechanisms. J Am Coll Cardiol. 2014;63(24):2722–2733.
   PubMed Web of Science ®Google Scholar
• Li H, Li C, Shen T, et al. R-eriodictyol and S-eriodictyol exhibited comparable effect against H2O2-induced oxidative stress in EA.hy926 cells. Drug Discov Ther. 2014;8(5):218–224.
   PubMedGoogle Scholar
• Greene L, Tischler A. Establishment of a noradrenergic clonal line of rat adrenal pheochromocytoma cells which respond to nerve growth factor. Proc Natl Acad Sci USA. 1976;73(7):2424–2428.
   PubMed Web of Science ®Google Scholar
• Offen D, Panet H, Melamed E. Catechol-O-methyltransferase reduced levodopa toxicity in PC12 cells: implications for treatment of Parkinson's disease. Ann Neurol. 1999;46(3):459–459.
   Web of Science ®Google Scholar
• Sun H-J, Wang Y, Hao T, et al. Efficient GSH delivery using PAMAM-GSH into MPP-induced PC12 cellular model for Parkinson's disease. Regen Biomater. 2016;3(5):299–307.
   PubMed Web of Science ®Google Scholar
• Kujoth GC, Hiona A, Pugh TD, et al. Mitochondrial DNA mutations, oxidative stress, and apoptosis in mammalian aging. Science. 2005;309(5733):481–484.
   PubMed Web of Science ®Google Scholar
• Tatton NA. Increased caspase 3 and Bax immunoreactivity accompany nuclear GAPDH translocation and neuronal apoptosis in Parkinson's disease. Exp Neurol. 2000;166(1):29–43.
   PubMed Web of Science ®Google Scholar
• Jacobson MD. Reactive oxygen species and programmed cell death. Trends Biochem Sci. 1996;21(3):83–86.
   PubMed Web of Science ®Google Scholar
• Andersen JK. Oxidative stress in neurodegeneration: cause or consequence? Nat Med. 2004;10(S7):S18–S25.
   PubMed Web of Science ®Google Scholar
• Halliwell B. Reactive oxygen species and the central nervous system. J Neurochem. 1992;59(5):1609–1623.
   PubMed Web of Science ®Google Scholar
• Moreno-Navarrete JM, Catalán V, Ortega F, et al. Circulating omentin concentration increases after weight loss. Nutr Metab. 2010;7(1):27.
   Google Scholar
• Zhong X, Zhang H-y, Tan H, et al. Association of serum omentin-1 levels with coronary artery disease. Acta Pharmacol Sin. 2011;32(7):873–878.
   PubMed Web of Science ®Google Scholar
• Kazama K, Usui T, Okada M, et al. Omentin plays an anti-inflammatory role through inhibition of TNF-α-induced superoxide production in vascular smooth muscle cells. Eur J Pharmacol. 2012;686(1–3):116–123.
   PubMed Web of Science ®Google Scholar
• Zhang G, Chen L, Liu J, et al. HIF-1α/microRNA-128-3p axis protects hippocampal neurons from apoptosis via the Axin1-mediated Wnt/β-catenin signaling pathway in Parkinson's disease models. Aging. 2020;12(5):4067–4081.
   PubMedGoogle Scholar
• Liu J, Wang S, Zhang Q, et al. Selenomethionine alleviates LPS-induced chicken myocardial inflammation by regulating the miR-128-3p-p38 MAPK axis and oxidative stress. Metallomics. 2020;12(1):54–64.
   PubMed Web of Science ®Google Scholar
• Zanoni M, Orlandi E, Rossetti G, et al. Upregulated serum miR-128-3p in progressive and relapse-free multiple sclerosis patients. Acta Neurol Scand. 2020;142(5):511–516.
   PubMed Web of Science ®Google Scholar
• Mou T, Luo Y, Huang Z, et al. Inhibition of microRNA-128-3p alleviates liver ischaemia-reperfusion injury in mice through repressing the Rnd3/NF-κB axis. Innate Immun. 2020;26(6):528–536.
   PubMed Web of Science ®Google Scholar
• Mao G, Ren P, Wang G, et al. MicroRNA-128-3p protects mouse against cerebral ischemia through reducing p38α mitogen-activated protein kinase activity. J Mol Neurosci. 2017;61(2):152–158.
   PubMed Web of Science ®Google Scholar